FDA OKs First Novel Nonsteroidal Topical for Plaque Psoriasis in 25 Years
Complete, near-complete clearance in 35-40% of patients treated with tapinarof cream 1%
Stay updated with breaking news from Mark Lebwohl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Complete, near-complete clearance in 35-40% of patients treated with tapinarof cream 1%
/PRNewswire/ -- Boehringer Ingelheim announced today the publication in The New England Journal of Medicine of new data from the pivotal Phase II Effisayil™ 1...
Mount Sinai researcher shows novel drug significantly improves signs and symptoms of generalized pustular psoriasis—a rare and life-threatening
/PRNewswire/ -- Boehringer Ingelheim announced today the publication in The New England Journal of Medicine of new data from the pivotal Phase II Effisayil™ 1...
Newly published results showed spesolimab significantly improved signs and symptoms of flares in rare, life-threatening skin disease, generalized pustular psoriasis - read this article along with other careers information, tips and advice on BioSpace